This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 1002624
Submitted by lobbyist on: July 30, 2019 05:42:47 AM
Accepted by Registrar on: July 30, 2019 03:50:59 PM
Designated Filer Information
| Robidoux, Michel |
| 110 rue de Lauzon | |
|
Boucherville, QC, J4B 1E6
|
450-641-4903 |
| Canada |
Organization Information
| Sandoz Canada Inc. |
| Sandoz is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to discover new ways to improve and extend people's lives. For further information please visit www.sandoz.ca |
| 110 rue de Lauzon | |
|
Boucherville, QC, J4B 1E6
|
450-641-4903 |
| Canada |
Relevant Affiliates
Type:
| Business Name | Mailing Address | Contact Information |
|---|---|---|
| Novartis Pharmaceuticals Inc. |
385 Boul Bouchard
Dorval, QC H9S 1A9 Canada |
Phone: 514-631-6775 |
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
| July 30, 2019 | |
| January 30, 2020 |
Organization's In-House Lobbyists
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Introduction, modification or repeal of legislation, a bill or regulation
Discuss matters to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc. Raising awareness to government officials of generics and biosimilars products development by Sandoz Canada and the potential savings realized by healthcare system. Improve regulatory environment and utilization rates for generics and biosimilars. Improve regulatory environment to allow pharmacies in British Columbia to sell and distribute medical cannabis to patients. Raise awareness of digital treatment solutions to treat patients with addictions.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Darcy, Judy | Minister of Mental Health and Addictions | July 30, 2019 |
| Minister | Dix, Adrian | Minister of Health | July 30, 2019 |
| Minister | Horgan, John | Premier | July 30, 2019 |
| Minister | James, Carole | Minister of Finance | July 30, 2019 |
| MLA | Isaacs, Joan | Coquitlam-Burke Mountain | July 30, 2019 |
| MLA | Letnick, Norm | Kelowna-Lake Country | July 30, 2019 |
| Public Agency | Health | July 30, 2019 | |
| Public Agency | Mental Health and Addictions | July 30, 2019 | |
| Public Agency | The University of British Columbia | July 30, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Raising awareness of government officials of generic product development by Sandoz Canada and the potential savings realized by the healthcare system. Increase utilization rate for generics. Raise awareness of digital treatment solutions to treat patients with addictions
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | July 30, 2019 | |
| Public Agency | Mental Health and Addictions | July 30, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Raising awareness of government officials of biosimilar product development by Sandoz Canada and the potential savings realized by the healthcare system. Increase utilization rate for biosimilars.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Dix, Adrian | Minister of Health | July 30, 2019 |
| Staff of Minister | Singh, Jasmyn | Minister of Health | July 30, 2019 |
| Public Agency | Health | July 30, 2019 | |
| Public Agency | The University of British Columbia | July 30, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Introduction, modification or repeal of legislation, a bill or regulation
Discuss matters to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc. Raising awareness to government officials of generics and biosimilars products development by Sandoz Canada and the potential savings realized by healthcare system. Improve regulatory environment and utilization rates for generics and biosimilars. Improve regulatory environment to allow pharmacies in British Columbia to sell and distribute medical cannabis to patients. Raise awareness of digital treatment solutions to treat patients with addictions.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Darcy, Judy | Minister of Mental Health and Addictions | July 30, 2019 |
| Minister | Dix, Adrian | Minister of Health | July 30, 2019 |
| Minister | Horgan, John | Premier | July 30, 2019 |
| Minister | James, Carole | Minister of Finance | July 30, 2019 |
| Staff of Minister | Singh, Jasmyn | Minister of Health | July 30, 2019 |
| MLA | Isaacs, Joan | Coquitlam-Burke Mountain | July 30, 2019 |
| MLA | Letnick, Norm | Kelowna-Lake Country | July 30, 2019 |
| MLA | Yap, John | Richmond-Steveston | July 30, 2019 |
| Public Agency | Health | July 30, 2019 | |
| Public Agency | Mental Health and Addictions | July 30, 2019 | |
| Public Agency | The University of British Columbia | July 30, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Raising awareness of government officials of biosimilar product development by Sandoz Canada and the potential savings realized by the healthcare system. Increase utilization rate for biosimilars.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | July 30, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Introduction, modification or repeal of legislation, a bill or regulation
Discuss matters to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc. Raising awareness to government officials of generics and biosimilars products development by Sandoz Canada and the potential savings realized by healthcare system. Improve regulatory environment and utilization rates for generics and biosimilars. Improve regulatory environment to allow pharmacies in British Columbia to sell and distribute medical cannabis to patients. Raise awareness of digital treatment solutions to treat patients with addictions.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Darcy, Judy | Minister of Mental Health and Addictions | July 30, 2019 |
| Minister | Dix, Adrian | Minister of Health | July 30, 2019 |
| Minister | Horgan, John | Premier | July 30, 2019 |
| Minister | James, Carole | Minister of Finance | July 30, 2019 |
| MLA | Isaacs, Joan | Coquitlam-Burke Mountain | July 30, 2019 |
| MLA | Letnick, Norm | Kelowna-Lake Country | July 30, 2019 |
| Public Agency | Health | July 30, 2019 | |
| Public Agency | Mental Health and Addictions | July 30, 2019 | |
| Public Agency | The University of British Columbia | July 30, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Raising awareness of government officials of biosimilar product development by Sandoz Canada and the potential savings realized by the healthcare system. Increase utilization rate for biosimilars.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | July 30, 2019 | |
| Public Agency | Provincial Health Services Authority | July 30, 2019 | |
| Public Agency | The University of British Columbia | July 30, 2019 |